231 related articles for article (PubMed ID: 19160016)
1. Targeting group II PAKs in cancer and metastasis.
Eswaran J; Soundararajan M; Knapp S
Cancer Metastasis Rev; 2009 Jun; 28(1-2):209-17. PubMed ID: 19160016
[TBL] [Abstract][Full Text] [Related]
2. Emerging functions of p21-activated kinases in human cancer cells.
Kumar R; Vadlamudi RK
J Cell Physiol; 2002 Nov; 193(2):133-44. PubMed ID: 12384990
[TBL] [Abstract][Full Text] [Related]
3. UnPAKing the class differences among p21-activated kinases.
Eswaran J; Soundararajan M; Kumar R; Knapp S
Trends Biochem Sci; 2008 Aug; 33(8):394-403. PubMed ID: 18639460
[TBL] [Abstract][Full Text] [Related]
4. p21-activated kinases in cancer.
Kumar R; Gururaj AE; Barnes CJ
Nat Rev Cancer; 2006 Jun; 6(6):459-71. PubMed ID: 16723992
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
Szczepanowska J
Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
[TBL] [Abstract][Full Text] [Related]
6. P21-activated kinases in human cancer.
Vadlamudi RK; Kumar R
Cancer Metastasis Rev; 2003 Dec; 22(4):385-93. PubMed ID: 12884913
[TBL] [Abstract][Full Text] [Related]
7. PAK as a therapeutic target in gastric cancer.
Li X; Liu F; Li F
Expert Opin Ther Targets; 2010 Apr; 14(4):419-33. PubMed ID: 20146633
[TBL] [Abstract][Full Text] [Related]
8. P21 activated kinase signaling in cancer.
Rane CK; Minden A
Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
[TBL] [Abstract][Full Text] [Related]
9. Pak protein kinases and their role in cancer.
Dummler B; Ohshiro K; Kumar R; Field J
Cancer Metastasis Rev; 2009 Jun; 28(1-2):51-63. PubMed ID: 19165420
[TBL] [Abstract][Full Text] [Related]
10. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
Shao YG; Ning K; Li F
World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
[TBL] [Abstract][Full Text] [Related]
11. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
[TBL] [Abstract][Full Text] [Related]
12. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
Song B; Wang W; Zheng Y; Yang J; Xu Z
J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
[TBL] [Abstract][Full Text] [Related]
13. PAKs in human disease.
Chan PM; Manser E
Prog Mol Biol Transl Sci; 2012; 106():171-87. PubMed ID: 22340718
[TBL] [Abstract][Full Text] [Related]
14. NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different from that of PAK1.
Wang W; Lim L; Baskaran Y; Manser E; Song J
Biochem Biophys Res Commun; 2013 Aug; 438(1):169-74. PubMed ID: 23876315
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of p21-activated kinases (PAKs).
Rudolph J; Crawford JJ; Hoeflich KP; Wang W
J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
[TBL] [Abstract][Full Text] [Related]
16. The role of p21-activated kinases in pancreatic cancer.
Yeo D; He H; Baldwin GS; Nikfarjam M
Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
[TBL] [Abstract][Full Text] [Related]
17. PAK signalling in neuronal physiology.
Kreis P; Barnier JV
Cell Signal; 2009 Mar; 21(3):384-93. PubMed ID: 19036346
[TBL] [Abstract][Full Text] [Related]
18. P21 activated kinases: structure, regulation, and functions.
Rane CK; Minden A
Small GTPases; 2014; 5():. PubMed ID: 24658305
[TBL] [Abstract][Full Text] [Related]
19. The emerging importance of group II PAKs.
Wells CM; Jones GE
Biochem J; 2010 Jan; 425(3):465-73. PubMed ID: 20070256
[TBL] [Abstract][Full Text] [Related]
20. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
